Literature DB >> 16982738

Implications of gene-environment interaction in studies of gene variants in breast cancer: an example of dietary isoflavones and the D356N polymorphism in the sex hormone-binding globulin gene.

Yen-Ling Low1, Alison M Dunning, Mitch Dowsett, Robert N Luben, Kay-Tee Khaw, Nick J Wareham, Sheila A Bingham.   

Abstract

Studies to identify common genetic variants contributing to breast cancer risk often yield inconsistent results. Breast cancer is a complex disease involving both genetic and environmental determinants. Dietary isoflavones are thought to reduce breast cancer risk by stimulating circulating sex hormone-binding globulin (SHBG) levels. The SHBG gene contains a D356N polymorphism and the N variant is associated with reduced SHBG clearance compared with the D variant. In this study, we show a significant gene-environment interaction between SHBG D356N polymorphism and dietary isoflavone exposure on circulating SHBG levels in 1,988 postmenopausal women. SHBG levels were positively associated with isoflavones in women carrying the N variant (etap2 = 1.9%; P = 0.006) but not in women carrying only the D variant (etap2 = 0.0%; P = 0.999; P(interaction) = 0.019). This finding shows that the subtle effects of some genetic variants may be magnified and only become detectable in the presence of certain exposures. This gene-environment interaction might explain heterogeneity in studies associating SHBG gene variants and soy consumption with breast cancer risk in Far East population exposed to high isoflavone levels compared with populations with lower levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982738     DOI: 10.1158/0008-5472.CAN-06-2432

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Association between SHBG Asp327Asn (rs6259) polymorphism and breast cancer risk: a meta-analysis of 10,454 cases and 13,111 controls.

Authors:  Jue-Yu Zhou; Rong Shi; Hai-Lang Yu; Wen-Ling Zheng; Wen-Li Ma
Journal:  Mol Biol Rep       Date:  2012-06-19       Impact factor: 2.316

Review 2.  Endocrine disruption by dietary phyto-oestrogens: impact on dimorphic sexual systems and behaviours.

Authors:  Heather B Patisaul
Journal:  Proc Nutr Soc       Date:  2016-07-08       Impact factor: 6.297

3.  Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.

Authors:  Brenda Diergaarde; John D Potter; Eldon R Jupe; Sharmila Manjeshwar; Craig D Shimasaki; Thomas W Pugh; Daniele C Defreese; Bobby A Gramling; Ilonka Evans; Emily White
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-07       Impact factor: 4.254

4.  Sex hormone-binding globulin and risk of type 2 diabetes in women and men.

Authors:  Eric L Ding; Yiqing Song; JoAnn E Manson; David J Hunter; Cathy C Lee; Nader Rifai; Julie E Buring; J Michael Gaziano; Simin Liu
Journal:  N Engl J Med       Date:  2009-08-05       Impact factor: 91.245

5.  Sex hormone binding globulin in breast cancer.

Authors:  Dayalu Naik S L; Suresh Hedau; Anil Kumar Bahadur; Renuka Saha; Sudershan Kaur; Amitabha Ray
Journal:  Indian J Clin Biochem       Date:  2008-10-01

6.  The Asp(327)Asn polymorphism in the sex hormone-binding globulin gene modifies the association of soy food and tea intake with endometrial cancer risk.

Authors:  Wang Hong Xu; Wei Zheng; Qiuyin Cai; Jia-Rong Cheng; Hui Cai; Yong-Bing Xiang; Xiao Ou Shu
Journal:  Nutr Cancer       Date:  2008       Impact factor: 2.900

7.  The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.

Authors:  Eunjung Lee; Fredrick Schumacher; Juan Pablo Lewinger; Susan L Neuhausen; Hoda Anton-Culver; Pamela L Horn-Ross; Katherine D Henderson; Argyrios Ziogas; David Van Den Berg; Leslie Bernstein; Giske Ursin
Journal:  Breast Cancer Res       Date:  2011-04-01       Impact factor: 6.466

8.  Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine.

Authors:  Nicola Luigi Bragazzi
Journal:  Curr Pharmacogenomics Person Med       Date:  2013-06

Review 9.  Evaluation of the current knowledge limitations in breast cancer research: a gap analysis.

Authors:  Alastair Thompson; Keith Brennan; Angela Cox; Julia Gee; Diana Harcourt; Adrian Harris; Michelle Harvie; Ingunn Holen; Anthony Howell; Robert Nicholson; Michael Steel; Charles Streuli
Journal:  Breast Cancer Res       Date:  2008-03-27       Impact factor: 6.466

Review 10.  Equol: A Bacterial Metabolite from The Daidzein Isoflavone and Its Presumed Beneficial Health Effects.

Authors:  Baltasar Mayo; Lucía Vázquez; Ana Belén Flórez
Journal:  Nutrients       Date:  2019-09-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.